NCT06514651 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06514651
Title	MAQ-001 in Patients With Advanced Solid Tumors
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	MabQuest SA
Indications	endometrial cancer lung non-small cell carcinoma stomach cancer cervical cancer Advanced Solid Tumor Merkel cell carcinoma lung small cell carcinoma renal cell carcinoma melanoma Hodgkin's lymphoma sarcoma hepatocellular carcinoma transitional cell carcinoma skin squamous cell carcinoma alveolar soft part sarcoma head and neck squamous cell carcinoma basal cell carcinoma esophageal cancer triple-receptor negative breast cancer primary mediastinal B-cell lymphoma
Therapies	MAQ-001 Ipilimumab + MAQ-001
Age Groups:	adult \| senior
Covered Countries	FRA

Facility	Status	City	Country	Details
Centre Léon Bérard	NOT_YET_RECRUITING	Lyon	France	Details
Institut Gustave Roussy	NOT_YET_RECRUITING	Paris	France	Details
Centre Eugene Marquis	NOT_YET_RECRUITING	Rennes	France	Details
Oncopole Claudius Regaud Toulouse	RECRUITING	Toulouse	France	Details

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field

NCT06514651Clinical Trial Detail